Travere Therapeutics, Inc (NASDAQ:TVTX) Pursues Near-Term Approval Catalyst Following Strong Data
![]() |
Momentum from late-stage data presentations and regulatory review dynamics positions the company for a potential catalyst in the coming weeks, while short-term technicals signal friction that may compress near-term price action. |










